Neurocrine stock kpis
Want to see NBIX full AI Analyst Report?
Revenue by Segment
Shows how revenue is distributed across different business areas, highlighting which segments are driving growth and which may need strategic focus or improvement.
INGREZZA is the company’s core growth engine — sustained acceleration since 2023 drove management to raise full‑year INGREZZA guidance and underpins pro‑forma near‑$1B quarterly scale with the VYKAT XR deal. Smaller lines (Ongentys/Other, Collaboration) are inconsistent and immaterial, with Ongentys dropping to zero in recent quarters (likely reclassification/divestiture), so future revenue upside depends on Ingrezza durability, CRENESSITY uptake and successful integration/scale‑up of VYKAT XR; watch acquisition‑related cash use, GAAP charges and early‑launch churn as key near‑term risk factors.
NBIX Revenue by Segment
| Date | Ingrezza | Ongentys and Other Products | Collaboration and Other |
|---|---|---|---|
| Sep 30, 2026 | $801.00M | $0.00 | $111.00M |
| Jun 30, 2026 | $716.00M | $0.00 | $4.70M |
| Mar 31, 2026 | $656.90M | $0.00 | $4.30M |
| Dec 31, 2025 | $657.50M | $5.50M | $7.20M |
| Sep 30, 2025 | $686.60M | $5.20M | $5.00M |
| Jun 30, 2025 | $624.40M | $4.40M | $5.50M |
| Mar 31, 2025 | $545.20M | $4.00M | $8.90M |
| Dec 31, 2024 | $615.00M | $6.20M | $6.50M |
| Sep 30, 2024 | $612.90M | $3.70M | $5.50M |
| Jun 30, 2024 | $579.50M | $4.30M | $6.40M |
| Mar 31, 2024 | $506.00M | $3.00M | $6.30M |
| Dec 31, 2023 | $500.20M | $7.00M | $8.00M |
| Sep 30, 2023 | $485.70M | $6.10M | $7.00M |
| Jun 30, 2023 | $439.70M | $6.60M | $6.40M |
| Mar 31, 2023 | $410.40M | $4.90M | $5.10M |
| Dec 31, 2022 | $399.20M | $5.40M | $7.40M |
| Sep 30, 2022 | $376.40M | $2.90M | $8.60M |
| Jun 30, 2022 | $349.60M | $2.40M | $26.20M |
| Mar 31, 2022 | $302.60M | $2.40M | $5.60M |
| Dec 31, 2021 | $301.00M | $2.50M | $8.50M |
| Sep 30, 2021 | $286.50M | $2.30M | $7.20M |
| Jun 30, 2021 | $264.80M | $2.00M | $22.10M |
| Mar 31, 2021 | $229.60M | $1.40M | $5.60M |
| Dec 31, 2020 | $240.40M | $900.00K | $6.60M |
| Sep 30, 2020 | $254.00M | $100.00K | $4.40M |
| Jun 30, 2020 | $267.60M | $0.00 | $34.80M |
| Mar 31, 2020 | $0.00 | $0.00 | $6.00M |
| Dec 31, 2019 | $0.00 | $0.00 | $6.20M |
